InvestorsHub Logo
Followers 8
Posts 1204
Boards Moderated 0
Alias Born 07/21/2009

Re: stockmasterflash post# 53430

Tuesday, 05/09/2017 11:59:02 AM

Tuesday, May 09, 2017 11:59:02 AM

Post# of 59548
I thought Dean had filed a new patent.. Now we know..


On June 22, 2004 the United States Patent and Trademark Office (“USPTO”) issued Patent No. 6,754,297 covering the Technology to the Company as assignee. After making substantial improvements to the design and utility of the Technology, Janes, on June 21, 2004, filed a second patent application covering the Technology with the aforementioned improvements. On January 8, 2008, the USPTO issued patent No. 7,317,819 covering the improved Technology to the Company as assignee. On June 22, 2008 subsequent to the issuance of Patent No. 7,317,819, the Company intentionally allowed Patent No. 6,754,297 to expire for non-payment of required maintenance fees. Assuming continued payment of maintenance fees, U.S. Patent No. 7,317,819 expires no sooner than June 21, 2024; due to provisions in Title II of the Drug Price Competition and Patent Term Restoration Act, the patent term could be extended beyond this date.